fda warning letters compounded semaglutide october 2025 glp-1 enforcement news issued 25 to telehealth companies for false and misleading claims about products. US FDA sends 25 letters

This has led to concerns over the sources of compounded semaglutide and the use of different formulations, such as semaglutide sodium

Anti-inflammatory activity The therapeutic potential of sulforaphane has also been linked to its capacity to target pro-inflammatory pathways

If significant GI symptoms are present on the day of surgery (nausea, vomiting, bloating, abdominal pain, etc.), consider delaying the procedure

Collectively, these findings suggest that physiological or mildly elevated BL levels may confer protection against a range of diseases, including Parkinson's disease (PD)

A word of advice: Focus on body composition, not the number on the scale